News

The surrounding buzz is deafening, fuelled by incredible claims of effortless weight loss. But while Berberine, or Daru Haldi ...
Drugs such as Ozempic (a brand name for semaglutide) are showing promise for weight loss. Another medication in the same class has impressed in a recent phase 2 clinical trial – and it only ...
Amgen's MariTide showed strong weight loss and metabolic gains in Phase 2, with no new safety signals as Phase 3 trials begin in obesity and T2D.
Novo Nordisk reveals three new weight loss drugs, aiming to offer diverse options for obesity and weight management.
Amgen's long-acting experimental obesity drug MariTide needs to be given at a low starting dose to limit side effects like vomiting, according to mid-stage trial results presented at a medical ...
CHICAGO — Once-monthly maridebart cafraglutide resulted to significant weight loss at 1 year among adults with obesity, regardless of type 2 diabetes status, according to data from a phase 2 ...
Once-weekly amycretin, a novel peptide activating GLP-1, amylin, and calcitonin receptors, produced rapid, substantial, and sustained weight loss in adults with overweight or obesity during a ...
Beyond weight loss, the studies show that the novel agent led to additive reductions in HbA1c and blood pressure, and further improved other surrogate endpoints pertinent to cardiologists, in both ...
The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all these options stack up.
Insurance coverage for weight-loss drugs has recently increased, but typically only covers branded versions, according to consulting firm Mercer.
State Representative Josh Williams cited his own experiences with GLP-1s, medications that are commonly used for weight loss and to treat Type 2 Diabetes.